Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials.
Deltenre P, Trépo E, Rudler M, Monescillo A, Fraga M, Denys A, Doerig C, Fournier N, Moreno C, Moradpour D, Bureau C, Thabut D. Deltenre P, et al. Among authors: fournier n. Eur J Gastroenterol Hepatol. 2015 Sep;27(9):e1-9. doi: 10.1097/MEG.0000000000000403. Eur J Gastroenterol Hepatol. 2015. PMID: 26049710 Review.
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.
Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group. Parragi L, et al. Among authors: fournier n. J Crohns Colitis. 2018 Jun 28;12(7):811-818. doi: 10.1093/ecco-jcc/jjy040. J Crohns Colitis. 2018. PMID: 29617750 Free article.
Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
Cernoch PS, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group. Cernoch PS, et al. Among authors: fournier n. Dig Dis Sci. 2020 Sep;65(9):2654-2663. doi: 10.1007/s10620-019-05978-9. Epub 2019 Dec 3. Dig Dis Sci. 2020. PMID: 31797187 Free article.
Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease.
Yilmaz B, Juillerat P, Øyås O, Ramon C, Bravo FD, Franc Y, Fournier N, Michetti P, Mueller C, Geuking M, Pittet VEH, Maillard MH, Rogler G; Swiss IBD Cohort Investigators; Wiest R, Stelling J, Macpherson AJ. Yilmaz B, et al. Among authors: fournier n. Nat Med. 2019 Apr;25(4):701. doi: 10.1038/s41591-019-0411-9. Nat Med. 2019. PMID: 30846883
The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn's disease.
Schoepfer AM, Bortolotti M, Pittet V, Mottet C, Gonvers JJ, Reich O, Fournier N, Vader JP, Burnand B, Michetti P, Froehlich F. Schoepfer AM, et al. Among authors: fournier n. Aliment Pharmacol Ther. 2014 Oct;40(8):930-7. doi: 10.1111/apt.12929. Epub 2014 Aug 22. Aliment Pharmacol Ther. 2014. PMID: 25146487 Free article.
Topical therapy is underused in patients with ulcerative colitis.
Seibold F, Fournier N, Beglinger C, Mottet C, Pittet V, Rogler G; Swiss IBD cohort study group. Seibold F, et al. Among authors: fournier n. J Crohns Colitis. 2014 Jan;8(1):56-63. doi: 10.1016/j.crohns.2013.03.005. Epub 2013 Apr 6. J Crohns Colitis. 2014. PMID: 23566922 Free article.
268 results